179 related articles for article (PubMed ID: 26153330)
1. Current and future molecular diagnostics in non-small-cell lung cancer.
Li CM; Chu WY; Wong DL; Tsang HF; Tsui NB; Chan CM; Xue VW; Siu PM; Yung BY; Chan LW; Wong SC
Expert Rev Mol Diagn; 2015; 15(8):1061-74. PubMed ID: 26153330
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
3. Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
Zhou F; Moreira AL
Arch Pathol Lab Med; 2016 Dec; 140(12):1331-1337. PubMed ID: 27588333
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology.
Gridelli C; de Marinis F; Cappuzzo F; Di Maio M; Hirsch FR; Mok T; Morgillo F; Rosell R; Spigel DR; Yang JC; Ciardiello F
Clin Lung Cancer; 2014 May; 15(3):173-81. PubMed ID: 24486058
[TBL] [Abstract][Full Text] [Related]
5. The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer.
Ross K; Pailler E; Faugeroux V; Taylor M; Oulhen M; Auger N; Planchard D; Soria JC; Lindsay CR; Besse B; Vielh P; Farace F
Expert Rev Mol Diagn; 2015; 15(12):1605-29. PubMed ID: 26564313
[TBL] [Abstract][Full Text] [Related]
6. First-line therapy of mutated non-small cell lung cancer: an update.
Stöhlmacher-Williams J
Onkologie; 2012; 35(5):293-9. PubMed ID: 22868512
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach.
Salgia R
Future Oncol; 2015; 11(3):489-500. PubMed ID: 25675128
[TBL] [Abstract][Full Text] [Related]
8. Future options for ALK-positive non-small cell lung cancer.
Iacono D; Chiari R; Metro G; Bennati C; Bellezza G; Cenci M; Ricciuti B; Sidoni A; Baglivo S; Minotti V; Crinò L
Lung Cancer; 2015 Mar; 87(3):211-9. PubMed ID: 25601484
[TBL] [Abstract][Full Text] [Related]
9. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
Pirker R; Herth FJ; Kerr KM; Filipits M; Taron M; Gandara D; Hirsch FR; Grunenwald D; Popper H; Smit E; Dietel M; Marchetti A; Manegold C; Schirmacher P; Thomas M; Rosell R; Cappuzzo F; Stahel R;
J Thorac Oncol; 2010 Oct; 5(10):1706-13. PubMed ID: 20871269
[TBL] [Abstract][Full Text] [Related]
10. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
11. The anaplastic lymphoma kinase testing conundrum.
Conde E; Taniere P; Lopez-Rios F
Expert Rev Mol Diagn; 2015 Feb; 15(2):161-3. PubMed ID: 25579121
[TBL] [Abstract][Full Text] [Related]
12. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges].
Herth FJ; Bubendorf L; Gütz S; Morresi-Hauf A; Hummel M; Junker K; Lehmann U; Petersen I; Schnabel PA; Warth A
Pneumologie; 2013 Apr; 67(4):198-204. PubMed ID: 23576199
[TBL] [Abstract][Full Text] [Related]
14. Personalized therapy of lung cancer.
Thomas R; Wolf J
Onkologie; 2012; 35 Suppl 1():14-9. PubMed ID: 22286583
[TBL] [Abstract][Full Text] [Related]
15. Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement.
Fujiwara A; Higashiyama M; Kanou T; Tokunaga T; Okami J; Kodama K; Nishino K; Tomita Y; Okamoto I
Lung Cancer; 2014 Feb; 83(2):302-4. PubMed ID: 24360322
[TBL] [Abstract][Full Text] [Related]
16. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
[TBL] [Abstract][Full Text] [Related]
17. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
Rossi G; Graziano P; Leone A; Migaldi M; Califano R
Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286
[TBL] [Abstract][Full Text] [Related]
18. National Working Group Meeting on ALK diagnostics in lung cancer.
Cooper W; Fox S; O'Toole S; Morey A; Frances G; Pavlakis N; O'Byrne K; Dettrick A; Leong T; Rathi V; Spagnolo D; Hemmings C; Singh M; Moffat D; Tsao MS; Wilner K; Buller R; Pitman Lowenthal S; Arifeen S; Binko J; Alam M
Asia Pac J Clin Oncol; 2014 Apr; 10 Suppl 2():11-7. PubMed ID: 24673736
[TBL] [Abstract][Full Text] [Related]
19. TaqMan based real time PCR assay targeting EML4-ALK fusion transcripts in NSCLC.
Robesova B; Bajerova M; Liskova K; Skrickova J; Tomiskova M; Pospisilova S; Mayer J; Dvorakova D
Lung Cancer; 2014 Jul; 85(1):25-30. PubMed ID: 24792336
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvement.
Slavik T; Asselah F; Fakhruddin N; El Khodary A; Torjman F; Anis E; Quinn M; Khankan A; Kerr KM
Clin Lung Cancer; 2014 Nov; 15(6):398-404. PubMed ID: 25043210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
